Oxycodon-Hcl 1 × Täglich Beta (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodon-Hcl 1 × Täglich Beta, is an opioid analgesic presented as a tablet for oral use. It treats moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxycodon-Hcl 1 × Daily Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid analgesic used in the management of pain across several clinical contexts. - Acute postoperative pain: Provides rapid relief of pain following surgical procedures. - Cancer‑related pain: Helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: Reduces pain intensity in conditions such as severe osteoarthritis when other treatments have failed.

Adverse reactions to oxycodone vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: light‑headed sensation, especially when standing. - Dry mouth: reduced salivation causing a parched feeling. - Sweating: excessive perspiration without exertion.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure leading to fainting. - Seizures: uncontrolled electrical activity in the brain. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Dependence and addiction: psychological or physical reliance on the drug. - Adrenal insufficiency: impaired cortisol production causing fatigue and weakness.

When prescribing oxycodone, clinicians should consider several safety measures. - Assess pain severity and prior opioid exposure: ensure appropriate indication before initiating therapy. - Evaluate respiratory function: monitor for signs of depression, especially in opioid‑naïve patients. - Review concomitant medications: avoid combinations that increase sedation or respiratory risk. - Counsel on constipation management: recommend dietary fiber, fluids, and laxatives as needed. - Educate on misuse potential: discuss risks of dependence, diversion, and proper storage. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone may interact with a range of medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression and excessive sedation. - Central nervous system depressants: other opioids, barbiturates, or alcohol markedly increase overdose risk. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise oxycodone plasma levels, heightening toxicity.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may reduce conversion to active metabolites, affecting analgesia. - Anticholinergic agents: can worsen constipation, a common opioid side effect. - Diuretics: may enhance hypotensive effects, requiring blood pressure monitoring.